NCT02912117View on ClinicalTrials.gov

Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay

CompletedOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

May 31, 2018

Conditions
InfectionNeutropenia
Trial Locations (1)

94305

Stanford University Hospital, Stanford

All Listed Sponsors
collaborator

Stanford University

OTHER

lead

Karius, Inc.

INDUSTRY

NCT02912117 - Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay | Biotech Hunter | Biotech Hunter